← Back to Search

Other

Septal Stapler for Nasal Congestion

N/A
Waitlist Available
Led By Erin D Wright, MDCM, FRCSC
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two methods of closing a septoplasty: suture and septal stapler. The primary objective is to determine if the stapler is faster. The secondary objectives are to compare patient outcomes and complications between the two groups.

Eligible Conditions
  • Nasal Congestion
  • Nasal Obstruction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Operative Time
Secondary study objectives
Post-operative Complications
Subjective Function

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Septal StaplerExperimental Treatment1 Intervention
This group will have closure of their nasal septal flaps via septal stapler.
Group II: Control (Suture)Active Control1 Intervention
This arm will have closure of their nasal septal flaps as routinely performed with suture passed in a quilting fashion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Septal Stapler
2012
N/A
~20

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,897 Total Patients Enrolled
Erin D Wright, MDCM, FRCSCPrincipal InvestigatorUniversity of Alberta
~1 spots leftby Nov 2025